As of Jan 20
| -0.05 / -3.82%|
The 6 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 2.25, with a high estimate of 4.50 and a low estimate of 1.50. The median estimate represents a +78.57% increase from the last price of 1.26.
The current consensus among 6 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.